Related Experiment Videos
Amoxapine-induced cognitive impairment in two patients
The Journal of Clinical Psychiatry
|April 1, 1987
Summary
Therapeutic doses of amoxapine may cause subtle cognitive impairments in patients. This is particularly relevant for managing depression in individuals with existing dementia.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Amoxapine is a tetracyclic antidepressant used for treating depression.
- Cognitive function is crucial for daily living and is often impaired in dementia.
Observation:
- Two patients receiving therapeutic amoxapine doses exhibited subtle cognitive deficits.
- These impairments were noted despite adherence to standard dosages.
Findings:
- A potential association exists between amoxapine treatment and cognitive impairment.
- The observed cognitive effects were subtle, not overtly severe.
Implications:
- Clinicians should monitor cognitive function in patients on amoxapine, especially those with dementia.
- Alternative antidepressant strategies may be warranted for depressed patients with cognitive vulnerabilities.
- Further research is needed to elucidate the neurobiological mechanisms underlying amoxapine-induced cognitive changes.